World's Best Scientists 2026 revealed!
Christian Gisselbrecht

Christian Gisselbrecht

D-Index & Metrics

Medicine

D-Index
94
Citations
50407
World Ranking
10262
National Ranking
320

Overview

Christian Gisselbrecht is affiliated with Université Paris Cité in France and focuses primarily on medical research, with a significant concentration in oncology and hematology.

Their research spans several specialized subfields including pathology and forensic medicine, oncology, hematology, genetics, and molecular biology. Within these areas, the scientist has contributed extensively to topics such as lymphoma diagnosis and treatment, CAR-T cell therapy research, CNS lymphoma diagnosis and treatment, chronic myeloid leukemia treatments, multiple myeloma research and treatments, protein degradation and inhibitors, and acute myeloid leukemia research.

Christian Gisselbrecht has published papers in a variety of scientific journals. Some recent significant publications include:

  • Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma, 2021, Blood Advances
  • A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL, 2020, Blood
  • EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma, 2020, The Oncologist
  • EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma, 2020, The Oncologist
  • Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective, 2020, BMC Cancer

The frequent co-authors who have collaborated with Christian Gisselbrecht include:

  • Francesco Pignatti
  • Harald Enzmann
  • Julio Delgado
  • Michael Crump
  • Norbert Schmitz

The scientist regularly publishes work in several journals, the most frequent being:

  • The Oncologist
  • HemaSphere
  • Blood Advances
  • Blood
  • BMC Cancer

Christian Gisselbrecht's overall contribution to medicine includes 42 publications, with a notable focus on lymphoma and hematological malignancies. Their interdisciplinary expertise covers both clinical treatment evaluation and the biological mechanisms underlying hematological diseases.

Best Publications

  • CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Bertrand Coiffier;Eric Lepage;Josette Briere;Raoul Herbrecht

  • A predictive model for aggressive non-Hodgkin's lymphoma

    M. A. Shipp;D. P. Harrington;J. R. Anderson;J. O. Armitage

  • Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

    T Philip;C Guglielmi;A Hagenbeek;R Somers

  • Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    P Feugier;A. Van Hoof;C. Sebban;P. Solal-Celigny

  • Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

    Christian Gisselbrecht;Bertram Glass;Nicolas Mounier;Devinder Singh Gill

  • Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

    Michael Crump;Sattva S. Neelapu;Umar Farooq;Eric Van Den Neste

  • A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

    Eva Hoster;Martin Dreyling;Wolfram Klapper;Christian Gisselbrecht

  • Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

    Georg Hess;Raoul Herbrecht;Jorge Romaguera;Gregor Verhoef

  • Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

    Martin Dreyling;Georg Lenz;Eva Hoster;Achiel Van Hoof

  • Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

    Nicolas Mounier;Josette Briere;Christian Gisselbrecht;Jean-Francois Emile

  • European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

    James M. Foran;Ama Z. S. Rohatiner;David Cunningham;Razvan A. Popescu

  • Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

    Owen A. O'Connor;Barbara Pro;Lauren Pinter-Brown;Nancy Bartlett

  • Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas

    Christian Gisselbrecht;Philippe Gaulard;Eric Lepage;Bertrand Coiffier

  • The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

    Laurence de Leval;David S. Rickman;Caroline Thielen;Aurélien de Reynies

  • Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

    Corinne Haioun;Eric Lepage;Christian Gisselbrecht;Gilles Salles

  • Prognostic significance of survivin expression in diffuse large B-cell lymphomas

    Colette Adida;Corinne Haioun;Philippe Gaulard;Eric Lepage

  • Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

    Hervé Tilly;Eric Lepage;Bertrand Coiffier;Michel Blanc

  • Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

    Anjali Advani;Bertrand Coiffier;Myron S. Czuczman;Martin Dreyling

  • Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

    C. Haioun;E. Lepage;C. Gisselbrecht;Y. Bastion

  • Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

    Nathalie Mourad;Nicolas Mounier;Josette Brière;Emmanuel Raffoux

Frequent Co-Authors

Bertrand Coiffier
Bertrand Coiffier Centre Hospitalier Lyon Sud
Hervé Tilly
Hervé Tilly Grenoble Alpes University
Corinne Haioun
Corinne Haioun Paris-Est Créteil University
Philippe Gaulard
Philippe Gaulard Université Paris Cité
Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Norbert Schmitz
Norbert Schmitz University of Münster
Raoul Herbrecht
Raoul Herbrecht University of Strasbourg
Massimo Federico
Massimo Federico University of Modena and Reggio Emilia
Martin Dreyling
Martin Dreyling Ludwig-Maximilians-Universität München
Eric D. Hsi
Eric D. Hsi Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in Medicine in the USA, you may want to consider related online degrees and alternative healthcare pathways. These options can offer more flexibility, lower tuition, and diverse career opportunities. Many students opt for programs such as a HIM degree online to gain expertise in health data management. With the healthcare field’s growing reliance on digital records, this role is in high demand.

Another popular option is pursuing medical billing and coding. The medical coding certification cost is generally much lower than full medical degrees, while still offering promising job prospects in administrative healthcare settings.

For those interested in advanced nursing roles, you might explore the cheapest online acute care nurse practitioner programs or look for affordable nursing programs online. These pathways allow you to make a significant impact on patient care, all while benefiting from the convenience and affordability of remote study.

Best Scientists Citing Christian Gisselbrecht

Trending Scientists

Recently Published Articles